Gilead’s $2,340 Price for Coronavirus Drug Draws Criticism

Remdesivir, a drug that is shown to shorten recovery time for severely ill COVID-19 patients, will cost $2,340 with insurance after a donated supply runs out at the beginning of July.

  • Published 29 June 2020

This article was republished here with permission from The Associated Press, however it is no longer available to read on Snopes.com.

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors.… Read at AP News